4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-034167
CEO & Chief Scientific Officer bought 40,000 shares at an average $16.07 ($642,824)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Scientific Officer | 2018-05-15 | Purchase | +25,000 | $16.08 | $401,970 | 2,065,619 | D |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2018-05-16 | Purchase | +15,000 | $16.06 | $240,854 | 2,080,619 | D |
| Open-market purchases · 40,000 sh · avg $16.07 · $642,824 | |||||||
Loading xslF345X03/a4.xml…